{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:09:19Z","timestamp":1790309359525,"version":"4.1.0"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:00:00Z","timestamp":1719014400000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jconrel.2023.06.008","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T18:35:26Z","timestamp":1687458926000},"page":"69-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Fibronectin-targeted FUD and PEGylated FUD peptides for fibrotic diseases"],"prefix":"10.1016","volume":"360","author":[{"given":"Hye Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca R.","family":"Tomasini-Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen S.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 24","key":"10.1016\/j.jconrel.2023.06.008_bb0005","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1242\/jcs.023820","article-title":"The extracellular matrix at a glance","volume":"123","author":"Frantz","year":"2010","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1172\/JCI93557","article-title":"Extracellular matrix as a driver of progressive fibrosis","volume":"128","author":"Herrera","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.jconrel.2023.06.008_bb0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1242\/dmm.004077","article-title":"Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer","volume":"4","author":"Cox","year":"2011","journal-title":"Dis. Model. Mech."},{"issue":"7835","key":"10.1016\/j.jconrel.2023.06.008_bb0020","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.06.008_bb0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","article-title":"Extracellular matrix in the tumor microenvironment and its impact on cancer therapy","volume":"6","author":"Henke","year":"2019","journal-title":"Front. Mol. Biosci."},{"issue":"4","key":"10.1016\/j.jconrel.2023.06.008_bb0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1165\/rcmb.2019-0328TR","article-title":"Pirfenidone: molecular mechanisms and potential clinical applications in lung disease","volume":"62","author":"Ruwanpura","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.jconrel.2023.06.008_bb0035","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.jconrel.2023.06.008_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112285","article-title":"Antifibrotic therapies and progressive fibrosing interstitial lung disease (PF-ILD): building on INBUILD","volume":"10","author":"Shumar","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0045","doi-asserted-by":"crossref","first-page":"12062","DOI":"10.1038\/s41598-019-48593-4","article-title":"Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with idiopathic pulmonary fibrosis","volume":"9","author":"Kato","year":"2019","journal-title":"Sci. Rep."},{"issue":"5 Suppl","key":"10.1016\/j.jconrel.2023.06.008_bb0050","first-page":"96S","article-title":"Role of fibronectin in fibrotic lung disease. A growth factor for human lung fibroblasts","volume":"83","author":"Bitterman","year":"1983","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jconrel.2023.06.008_bb0055","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.3892\/mmr.2016.5673","article-title":"Fibronectin expression is critical for liver fibrogenesis in vivo and in vitro","volume":"14","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2023.06.008_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.addr.2015.11.014","article-title":"Fibronectin-targeted drug delivery in cancer","volume":"97","author":"Kumra","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"Pt 20","key":"10.1016\/j.jconrel.2023.06.008_bb0065","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1242\/jcs.00059","article-title":"Fibronectin at a glance","volume":"115","author":"Pankov","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2023.06.008_bb0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1755-1536-4-21","article-title":"Plasma and cellular fibronectin: distinct and independent functions during tissue repair","volume":"4","author":"To","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"11","key":"10.1016\/j.jconrel.2023.06.008_bb0075","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1096\/fj.10-154435","article-title":"EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPK\/Erk 1\/2-dependent signaling","volume":"24","author":"Kohan","year":"2010","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0080","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41420-020-00378-9","article-title":"FN-EDA mediates angiogenesis of hepatic fibrosis via integrin-VEGFR2 in a CD63 synergetic manner","volume":"6","author":"Su","year":"2020","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.jconrel.2023.06.008_bb0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10456-005-9017-6","article-title":"EDB fibronectin and angiogenesis \u2013 a novel mechanistic pathway","volume":"8","author":"Khan","year":"2005","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jconrel.2023.06.008_bb0090","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fonc.2020.00641","article-title":"Shaping up the tumor microenvironment with cellular fibronectin","volume":"10","author":"Efthymiou","year":"2020","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.jconrel.2023.06.008_bb0095","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/iub.493","article-title":"Fibronectin splice variants: understanding their multiple roles in health and disease using engineered mouse models","volume":"63","author":"White","year":"2011","journal-title":"IUBMB Life"},{"issue":"4","key":"10.1016\/j.jconrel.2023.06.008_bb0100","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1039\/C6TB02008A","article-title":"Targeting fibronectin for cancer imaging and therapy","volume":"5","author":"Han","year":"2017","journal-title":"J. Mater. Chem. B"},{"issue":"10","key":"10.1016\/j.jconrel.2023.06.008_bb0105","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1091\/mbc.e02-01-0048","article-title":"Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions","volume":"13","author":"Sottile","year":"2002","journal-title":"Mol. Biol. Cell"},{"issue":"9","key":"10.1016\/j.jconrel.2023.06.008_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092443","article-title":"Fibronectin: molecular structure, fibrillar structure and mechanochemical signaling","volume":"10","author":"Dalton","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.jconrel.2023.06.008_bb0115","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1073\/pnas.91.11.5187","article-title":"Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice","volume":"91","author":"Hines","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.jconrel.2023.06.008_bb0120","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1159\/000493217","article-title":"Signaling mechanisms of myofibroblastic activation: outside-in and inside-out","volume":"49","author":"Zent","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"26","key":"10.1016\/j.jconrel.2023.06.008_bb0125","doi-asserted-by":"crossref","first-page":"23430","DOI":"10.1074\/jbc.M103467200","article-title":"A 49-residue peptide from adhesin F1 of Streptococcus pyogenes inhibits fibronectin matrix assembly","volume":"276","author":"Tomasini-Johansson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2023.06.008_bb0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev-cellbio-100109-104020","article-title":"Assembly of fibronectin extracellular matrix","volume":"26","author":"Singh","year":"2010","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.jconrel.2023.06.008_bb0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/10409238.2016.1184224","article-title":"Dynamic structure of plasma fibronectin","volume":"51","author":"Maurer","year":"2015","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.jconrel.2023.06.008_bb0140","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0026-895X(24)26508-1","article-title":"Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases","volume":"57","author":"Ishizaki","year":"2000","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1091\/mbc.e06-08-0684","article-title":"Fibronectin matrix assembly requires distinct contributions from rho kinases I and -II","volume":"18","author":"Yoneda","year":"2007","journal-title":"Mol. Biol. Cell"},{"issue":"4\u20135","key":"10.1016\/j.jconrel.2023.06.008_bb0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10974-004-6060-7","article-title":"Specificity of blebbistatin, an inhibitor of myosin II","volume":"25","author":"Limouze","year":"2004","journal-title":"J. Muscle Res. Cell Motil."},{"issue":"2","key":"10.1016\/j.jconrel.2023.06.008_bb0155","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bpj.2008.10.009","article-title":"Cell traction forces direct fibronectin matrix assembly","volume":"96","author":"Lemmon","year":"2009","journal-title":"Biophys. J."},{"issue":"7","key":"10.1016\/j.jconrel.2023.06.008_bb0160","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1016\/S0021-9258(18)61453-X","article-title":"Fibronectin\u2019s cell-adhesive domain and an amino-terminal matrix assembly domain participate in its assembly into fibroblast pericellular matrix","volume":"262","author":"McDonald","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.jconrel.2023.06.008_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069343","article-title":"Fibrotic remodeling of the extracellular matrix through a novel (engineered, dual-function) antibody reactive to a cryptic epitope on the N-terminal 30 kDa fragment of fibronectin","volume":"8","author":"Sharma","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.06.008_bb0170","doi-asserted-by":"crossref","first-page":"30872","DOI":"10.1038\/srep30872","article-title":"Control of fibrotic changes through the synergistic effects of anti-fibronectin antibody and an RGDS-tagged form of the same antibody","volume":"6","author":"Tiwari","year":"2016","journal-title":"Sci. Rep."},{"issue":"34","key":"10.1016\/j.jconrel.2023.06.008_bb0175","doi-asserted-by":"crossref","first-page":"12254","DOI":"10.1073\/pnas.0803556105","article-title":"Crystal structures of fibronectin-binding sites from Staphylococcus aureus FnBPA in complex with fibronectin domains","volume":"105","author":"Bingham","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0180","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41467-017-01846-0","article-title":"Novel peptide probes to assess the tensional state of fibronectin fibers in cancer","volume":"8","author":"Arnoldini","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.06.008_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbplus.2020.100046","article-title":"Fibronectin fibers are highly tensed in healthy organs in contrast to tumors and virus-infected lymph nodes","volume":"8","author":"Fonta","year":"2020","journal-title":"Matrix Biol. Plus"},{"issue":"5","key":"10.1016\/j.jconrel.2023.06.008_bb0190","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1039\/C9NR09585C","article-title":"A new tandem peptide modified liposomal doxorubicin for tumor \"ecological therapy\"","volume":"12","author":"Zhao","year":"2020","journal-title":"Nanoscale"},{"issue":"38","key":"10.1016\/j.jconrel.2023.06.008_bb0195","doi-asserted-by":"crossref","first-page":"35606","DOI":"10.1074\/jbc.M105417200","article-title":"Specific interactions between F1 adhesin of Streptococcus pyogenes and N-terminal modules of fibronectin","volume":"276","author":"Ensenberger","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2023.06.008_bb0200","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1083\/jcb.100.2.364","article-title":"Interaction of the 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts","volume":"100","author":"McKeown-Longo","year":"1985","journal-title":"J. Cell Biol."},{"issue":"5","key":"10.1016\/j.jconrel.2023.06.008_bb0205","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/j.1460-2075.1996.tb00435.x","article-title":"A two-domain mechanism for group A streptococcal adherence through protein F to the extracellular matrix","volume":"15","author":"Ozeri","year":"1996","journal-title":"EMBO J."},{"issue":"52","key":"10.1016\/j.jconrel.2023.06.008_bb0210","doi-asserted-by":"crossref","first-page":"41087","DOI":"10.1074\/jbc.M110.153692","article-title":"Extended binding site on fibronectin for the functional upstream domain of protein F1 of Streptococcus pyogenes","volume":"285","author":"Maurer","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.jconrel.2023.06.008_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124941","article-title":"On-off kinetics of engagement of FNI modules of soluble fibronectin by beta-strand addition","volume":"10","author":"Ma","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jconrel.2023.06.008_bb0220","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/ATVBAHA.108.181081","article-title":"Fibronectin is an important regulator of flow-induced vascular remodeling","volume":"29","author":"Chiang","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.jconrel.2023.06.008_bb0225","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/CIRCULATIONAHA.118.034609","article-title":"Inhibiting fibronectin attenuates fibrosis and improves cardiac function in a model of heart failure","volume":"138","author":"Valiente-Alandi","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jconrel.2023.06.008_bb0230","doi-asserted-by":"crossref","first-page":"F1293","DOI":"10.1152\/ajprenal.00117.2019","article-title":"Inhibition of fibronectin polymerization alleviates kidney injury due to ischemia-reperfusion","volume":"316","author":"Bowers","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"8","key":"10.1016\/j.jconrel.2023.06.008_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237932","article-title":"Disruption of fibronectin fibrillogenesis affects intraocular pressure (IOP) in BALB\/cJ mice","volume":"15","author":"Faralli","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jconrel.2023.06.008_bb0240","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jhep.2014.06.010","article-title":"Inhibition of fibronectin deposition improves experimental liver fibrosis","volume":"62","author":"Altrock","year":"2015","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.jconrel.2023.06.008_bb0245","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.neo.2021.06.012","article-title":"Inhibition of fibronectin accumulation suppresses TUMOR growth","volume":"23","author":"Ghura","year":"2021","journal-title":"Neoplasia"},{"key":"10.1016\/j.jconrel.2023.06.008_bb0250","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3389\/fimmu.2020.01501","article-title":"CD4(+) T cell interstitial migration controlled by fibronectin in the inflamed skin","volume":"11","author":"Fernandes","year":"2020","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.jconrel.2023.06.008_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205360","article-title":"PEGylated pUR4\/FUD peptide inhibitor of fibronectin fibrillogenesis decreases fibrosis in murine unilateral ureteral obstruction model of kidney disease","volume":"13","author":"Tomasini-Johansson","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jconrel.2023.06.008_bb0260","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1091\/mbc.e08-08-0830","article-title":"Fibrillin assembly requires fibronectin","volume":"20","author":"Sabatier","year":"2009","journal-title":"Mol. Biol. Cell"},{"issue":"5","key":"10.1016\/j.jconrel.2023.06.008_bb0265","first-page":"C1265","article-title":"Collagen I matrix turnover is regulated by fibronectin polymerization","volume":"298","author":"Shi","year":"2010","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"11","key":"10.1016\/j.jconrel.2023.06.008_bb0270","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1074\/jbc.M114.606186","article-title":"Myofibroblasts exhibit enhanced fibronectin assembly that is intrinsic to their contractile phenotype","volume":"290","author":"Torr","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2023.06.008_bb0275","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1083\/jcb.201007108","article-title":"Osteoblast mineralization requires beta1 integrin\/ICAP-1-dependent fibronectin deposition","volume":"194","author":"Brunner","year":"2011","journal-title":"J. Cell Biol."},{"issue":"9","key":"10.1016\/j.jconrel.2023.06.008_bb0280","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/01.ATV.18.9.1363","article-title":"Fibronectin: structure, assembly, and cardiovascular implications","volume":"18","author":"Magnusson","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.jconrel.2023.06.008_bb0285","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1101\/gad.1643308","article-title":"Fibronectin fibrillogenesis regulates three-dimensional neovessel formation","volume":"22","author":"Zhou","year":"2008","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.jconrel.2023.06.008_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094988","article-title":"Fibronectin matrix polymerization regulates smooth muscle cell phenotype through a Rac1 dependent mechanism","volume":"9","author":"Shi","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jconrel.2023.06.008_bb0295","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1182\/blood-2005-10-4168","article-title":"Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi","volume":"107","author":"Cho","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0300","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12929-019-0529-6","article-title":"Fibronectin inhibitor pUR4 attenuates tumor necrosis factor alpha-induced endothelial hyperpermeability by modulating beta1 integrin activation","volume":"26","author":"Lee","year":"2019","journal-title":"J. Biomed. Sci."},{"issue":"6459","key":"10.1016\/j.jconrel.2023.06.008_bb0305","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/367193a0","article-title":"Superfibronectin is a functionally distinct form of fibronectin","volume":"367","author":"Morla","year":"1994","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jconrel.2023.06.008_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2019.07.016","article-title":"Reprint of \u201cthe complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking\u201d","volume":"1867","author":"Gonzalez","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0315","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-5-15","article-title":"Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease","volume":"5","author":"Fan","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"8","key":"10.1016\/j.jconrel.2023.06.008_bb0320","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.RES.86.8.846","article-title":"Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium","volume":"86","author":"Heling","year":"2000","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2023.06.008_bb0325","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00441-005-0144-6","article-title":"Extracellular matrix remodeling in canine and mouse myocardial infarcts","volume":"324","author":"Dobaczewski","year":"2006","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0330","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1214243","article-title":"Acute kidney injury and chronic kidney disease as interconnected syndromes","volume":"371","author":"Chawla","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0335","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-1536-7-4","article-title":"The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?","volume":"7","author":"Genovese","year":"2014","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"4","key":"10.1016\/j.jconrel.2023.06.008_bb0340","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.exer.2008.01.013","article-title":"Extracellular matrix in the trabecular meshwork","volume":"86","author":"Acott","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2023.06.008_bb0345","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.exer.2017.08.017","article-title":"Disruption of fibronectin matrix affects type IV collagen, fibrillin and laminin deposition into extracellular matrix of human trabecular meshwork (HTM) cells","volume":"165","author":"Filla","year":"2017","journal-title":"Exp. Eye Res."},{"issue":"12","key":"10.1016\/j.jconrel.2023.06.008_bb0350","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1167\/iovs.19-27171","article-title":"Activation of alphavbeta3 integrin alters fibronectin fibril formation in human trabecular meshwork cells in a ROCK-independent manner","volume":"60","author":"Filla","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2023.06.008_bb0355","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s43152-021-00030-3","article-title":"Extracellular matrix remodeling in chronic liver disease","volume":"2","author":"Ortiz","year":"2021","journal-title":"Curr. Tissue Microenviron. Rep."},{"issue":"3","key":"10.1016\/j.jconrel.2023.06.008_bb0360","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ijc.20281","article-title":"Fibronectin stimulates human lung carcinoma cell growth by inducing cyclooxygenase-2 (COX-2) expression","volume":"111","author":"Han","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0365","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13046-021-01908-8","article-title":"Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology","volume":"40","author":"Spada","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.jconrel.2023.06.008_bb0370","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1158\/0008-5472.CAN-09-3312","article-title":"Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion","volume":"70","author":"Malik","year":"2010","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.jconrel.2023.06.008_bb0375","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.4049\/jimmunol.165.5.2738","article-title":"TNF-alpha associated with extracellular matrix fibronectin provides a stop signal for chemotactically migrating T cells","volume":"165","author":"Franitza","year":"2000","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2023.06.008_bb0380","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/imm.12972","article-title":"A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens","volume":"155","author":"Tomlin","year":"2018","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.jconrel.2023.06.008_bb0385","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/all.15120","article-title":"Specific T cells targeting Staphylococcus aureus fibronectin-binding protein 1 induce a type 2\/type 1 inflammatory response in sensitized atopic dermatitis patients","volume":"77","author":"Farag","year":"2022","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.jconrel.2023.06.008_bb0390","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.jconrel.2023.06.008_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113331","article-title":"Cancer extracellular matrix proteins regulate tumour immunity","volume":"12","author":"Gordon-Weeks","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cmi.2013.47","article-title":"Crawling of effector T cells on extracellular matrix: role of integrins in interstitial migration in inflamed tissues","volume":"11","author":"Kim","year":"2014","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0405","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1208\/s12248-014-9687-3","article-title":"Strategic approaches to optimizing peptide ADME properties","volume":"17","author":"Di","year":"2015","journal-title":"AAPS J."},{"issue":"5","key":"10.1016\/j.jconrel.2023.06.008_bb0410","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00063030-200822050-00004","article-title":"The impact of PEGylation on biological therapies","volume":"22","author":"Veronese","year":"2008","journal-title":"BioDrugs"},{"issue":"3","key":"10.1016\/j.jconrel.2023.06.008_bb0415","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.jconrel.2023.06.008_bb0420","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1124\/mol.105.014910","article-title":"Protein PEGylation decreases observed target association rates via a dual blocking mechanism","volume":"68","author":"Kubetzko","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"10","key":"10.1016\/j.jconrel.2023.06.008_bb0425","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1002\/jps.21278","article-title":"The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics","volume":"97","author":"Fishburn","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2023.06.008_bb0430","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","article-title":"PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs","volume":"105","author":"Turecek","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"20","key":"10.1016\/j.jconrel.2023.06.008_bb0435","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1021\/jm0497693","article-title":"Reversible PEGylation: a novel technology to release native interferon alpha2 over a prolonged time period","volume":"47","author":"Peleg-Shulman","year":"2004","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.jconrel.2023.06.008_bb0440","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s12072-020-10069-3","article-title":"Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study","volume":"14","author":"Poo","year":"2020","journal-title":"Hepatol. Int."},{"issue":"12","key":"10.1016\/j.jconrel.2023.06.008_bb0445","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1002\/iub.2389","article-title":"A long-acting isomer of ac-SDKP attenuates pulmonary fibrosis through SRPK1-mediated PI3K\/AKT and Smad2 pathway inhibition","volume":"72","author":"Qiu","year":"2020","journal-title":"IUBMB Life"},{"issue":"9","key":"10.1016\/j.jconrel.2023.06.008_bb0450","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/j.ijid.2011.05.002","article-title":"Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review","volume":"15","author":"Gao","year":"2011","journal-title":"Int. J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.jconrel.2023.06.008_bb0455","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/jir.2013.0067","article-title":"PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice","volume":"34","author":"Fam","year":"2014","journal-title":"J. Interf. Cytokine Res."},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0460","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12931-019-1171-2","article-title":"Interferon-gamma enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation","volume":"20","author":"Vu","year":"2019","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2023.06.008_bb0465","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jconrel.2011.05.027","article-title":"PEGylation improves pharmacokinetic profile, liver uptake and efficacy of interferon gamma in liver fibrosis","volume":"154","author":"Bansal","year":"2011","journal-title":"J. Control. Release"},{"issue":"48","key":"10.1016\/j.jconrel.2023.06.008_bb0470","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.jconrel.2023.06.008_bb0475","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/1061186X.2016.1262867","article-title":"Receptor-specific TRAIL as a means to achieve targeted elimination of activated hepatic stellate cells","volume":"25","author":"Arabpour","year":"2017","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0480","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.28432","article-title":"Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells","volume":"64","author":"Oh","year":"2016","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jconrel.2023.06.008_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/biom10071036","article-title":"Deoxyribonucleases and their applications in biomedicine","volume":"10","author":"Laukova","year":"2020","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.jconrel.2023.06.008_bb0490","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1021\/acs.molpharmaceut.2c00086","article-title":"Optimization of a liposomal DNase I formulation with an extended circulating half-life","volume":"19","author":"Penaloza Arias","year":"2022","journal-title":"Mol. Pharm."},{"issue":"13","key":"10.1016\/j.jconrel.2023.06.008_bb0495","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1042\/CS20180315","article-title":"Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum","volume":"132","author":"Guichard","year":"2018","journal-title":"Clin. Sci. (Lond.)"},{"issue":"2","key":"10.1016\/j.jconrel.2023.06.008_bb0500","article-title":"PEGylation of recombinant human deoxyribonuclease I provides a long-acting version of the mucolytic for patients with cystic fibrosis","volume":"4","author":"Guichard","year":"2020","journal-title":"Adv. Ther."},{"issue":"7","key":"10.1016\/j.jconrel.2023.06.008_bb0505","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11095-018-2412-7","article-title":"Characterization of the PEGylated functional upstream domain peptide (PEG-FUD): a potent fibronectin assembly inhibitor with potential as an anti-fibrotic therapeutic","volume":"35","author":"Zbyszynski","year":"2018","journal-title":"Pharm. Res."},{"issue":"7","key":"10.1016\/j.jconrel.2023.06.008_bb0510","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nchembio.2416","article-title":"Targeting the N terminus for site-selective protein modification","volume":"13","author":"Rosen","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.jconrel.2023.06.008_bb0515","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40259-018-0295-0","article-title":"Subcutaneous administration of biotherapeutics: an overview of current challenges and opportunities","volume":"32","author":"Bittner","year":"2018","journal-title":"BioDrugs"},{"issue":"Suppl. 17","key":"10.1016\/j.jconrel.2023.06.008_bb0520","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12919-021-00230-7","article-title":"Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert\u2019s and patient\u2019s perspective","volume":"15","author":"Jonaitis","year":"2021","journal-title":"BMC Proc."},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0525","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40580-019-0192-3","article-title":"Probing the subcutaneous absorption of a PEGylated FUD peptide nanomedicine via in vivo fluorescence imaging","volume":"6","author":"Zbyszynski","year":"2019","journal-title":"Nano Converg."},{"key":"10.1016\/j.jconrel.2023.06.008_bb0530","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jconrel.2022.08.028","article-title":"Multimodal imaging demonstrates enhanced tumor exposure of PEGylated FUD peptide in breast cancer","volume":"350","author":"Lee","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147600","article-title":"Fibronectin deposition participates in extracellular matrix assembly and vascular morphogenesis","volume":"11","author":"Hielscher","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jconrel.2023.06.008_bb0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102974","article-title":"Regulation of the innate immune response by fibronectin: synergism between the III-1 and EDA domains","volume":"9","author":"Kelsh","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jconrel.2023.06.008_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051270","article-title":"The dynamic relationship of breast cancer cells and fibroblasts in fibronectin accumulation at primary and metastatic tumor sites","volume":"12","author":"Libring","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.jconrel.2023.06.008_bb0550","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41419-021-03443-y","article-title":"Dynamically remodeled hepatic extracellular matrix predicts prognosis of early-stage cirrhosis","volume":"12","author":"Wu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2023.06.008_bb0555","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jps.23783","article-title":"Pharmacokinetics of peptide-Fc fusion proteins","volume":"103","author":"Wu","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2023.06.008_bb0560","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1002\/art.39232","article-title":"Rational design of antirheumatic prodrugs specific for sites of inflammation","volume":"67","author":"Onuoha","year":"2015","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jconrel.2023.06.008_bb0565","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12079-018-0492-0","article-title":"Protein PEGylation for cancer therapy: bench to bedside","volume":"13","author":"Gupta","year":"2019","journal-title":"J. Cell Commun. Signal."},{"issue":"7","key":"10.1016\/j.jconrel.2023.06.008_bb0570","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1177\/0192623315591171","article-title":"PEGylated biopharmaceuticals: current experience and considerations for nonclinical development","volume":"43","author":"Ivens","year":"2015","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2023.06.008_bb0575","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.894411","article-title":"Polyethylene glycol 20 kDa-induced vacuolation does not impair phagocytic function of human monocyte-derived macrophages","volume":"13","author":"Schoenbrunn","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2023.06.008_bb0580","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/85471","article-title":"Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis","volume":"7","author":"Sakai","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.06.008_bb0585","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(86)92931-4","article-title":"Plasma fibronectin deficiency in eight members of one family","volume":"1","author":"Shirakami","year":"1986","journal-title":"Lancet"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923003784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923003784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:44:57Z","timestamp":1759164297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923003784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":117,"alternative-id":["S0168365923003784"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.06.008","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibronectin-targeted FUD and PEGylated FUD peptides for fibrotic diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}